154 related articles for article (PubMed ID: 2849740)
1. The role of v-mos in transformation, oncogenicity, and metastatic potential of mink lung cells.
Gao CL; Wang LC; Vass WC; Seth A; Chang KS
Oncogene; 1988 Sep; 3(3):267-73. PubMed ID: 2849740
[TBL] [Abstract][Full Text] [Related]
2. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
O'Hara BM; Blair DG
Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
[TBL] [Abstract][Full Text] [Related]
3. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
4. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
5. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
6. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
[TBL] [Abstract][Full Text] [Related]
7. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
8. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
[TBL] [Abstract][Full Text] [Related]
9. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Radinsky R; Kraemer PM; Proffitt MR; Culp LA
Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
[TBL] [Abstract][Full Text] [Related]
10. A dominant suppressive mutation in a cellular gene restores the nontransformed phenotype to v-fms-transformed mink cells.
Kato J; Sherr CJ
Oncogene; 1991 May; 6(5):687-93. PubMed ID: 2052353
[TBL] [Abstract][Full Text] [Related]
11. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
12. Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line.
Gilmer TM; Lamb PW; Oshimura M; Barrett JC
Cancer Res; 1987 Sep; 47(17):4663-6. PubMed ID: 3040229
[TBL] [Abstract][Full Text] [Related]
13. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
[TBL] [Abstract][Full Text] [Related]
14. Functions of the mos oncogene family and associated gene products.
Bold RJ; Hannink M; Donoghue DJ
Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
[TBL] [Abstract][Full Text] [Related]
15. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
17. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
Somers KD; Murphey MM
Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties.
Bisgaard HC; Mackay AR; Gomez DE; Ton PT; Thorgeirsson SS; Thorgeirsson UP
Invasion Metastasis; 1997; 17(5):240-50. PubMed ID: 9876218
[TBL] [Abstract][Full Text] [Related]
19. Detection of a tumor-associated nucleoprotein antigen in mink lung cells transformed by two different viral oncogenes.
Dupere SL; Bulba AP; O'Connor TE
Cancer Res; 1987 May; 47(9):2284-7. PubMed ID: 3567922
[TBL] [Abstract][Full Text] [Related]
20. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
Lavialle C; Modjtahedi N; Cassingena R; Brison O
Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
